Research
Mixed
GLP-1 receptor agonist therapy induces lean mass loss proportional to fat loss (approx. 25% of total weight loss), which is a physiological response to caloric restriction rather than a unique pathological catabolic effect of the drug.
If you are taking a GLP-1 drug like Semaglutide, expect to lose about 25% of your total weight as muscle. This is normal and similar to losing weight through diet alone. To protect your muscle, prioritize resistance training and eat 1.2-1.6g of protein per kg of body weight daily.
GoodQualifiesHIGH confidence
Clinical trial evidence consistently shows that GLP-1RA therapy results in significant reductions in fat mass, accompanied by smaller but measurable decreases in lean mass... lean mass typically accounts for about one-quarter of total weight lost, this pattern is comparable to other weight-loss approaches and not uniquely harmful.
Why this rating
Based on multiple RCTs (STEP 1, SURMOUNT) and meta-analyses cited in the review.
Source
Muscle loss and GLP-1R agonists use
Giada Rossi et al. · Acta Diabetologica · 2025
DOI 10.1007/s00592-025-02611-2
narrative_reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Prevention of GLP-1RA-induced muscle loss requires a multimodal strategy combining resistance exercise, high protein intake (1.2-1.6 g/kg/day), and potentially specific supplements (BCAA, Creatine, Vitamin D).Good
- Mechanistically, GLP-1RA-induced muscle loss is driven by reduced protein intake, negative energy balance, and suppressed mTOR signaling due to lower insulin/IGF-1 levels, rather than direct myotoxicity.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →